Result card

  • ETH5: How are technologies presenting with relevantly similar (ethical) problems treated in health care system?
English
No adaptation help available for this domain

How are technologies presenting with relevantly similar (ethical) problems treated in health care system?

Authors: Gottfried Endel

Internal reviewers: Pseudo165 Pseudo165, Pseudo220 Pseudo220, Pseudo263 Pseudo263, Pseudo296 Pseudo296, Pseudo88 Pseudo88

Results from EFF, SAF and ECO domain answer this question perfectly.

Technologies with very similar benefits and risks in the same field of diseases are usually compared with methods of health economic evaluations. Either the regional health care system has a system with a more or less explicit willingness to pay framework or the appraisal process has to clarify if an increase in test accuracy (calculated into live years gained –LYG, quality adjusted life years gained – QUALY, incremental cost per LYG or QUALY) is seen as “good value for money”. This willingness to pay consideration may look at

  • Burden of disease – the epidemiology as documented in CUR domain
  • Severity and prognosis of disease – disease stages detected as shown in EFF domain
  • Follow up and treatment as discussed in EFF, SAF, ECO and ORG domain

Usually this considerations are guiding decisions on diagnostic tests in health care and in treatment.

Optional
Not
Endel G Result Card ETH5 In: Endel G Ethical analysis In: Jefferson T, Cerbo M, Vicari N [eds.]. Fecal Immunochemical Test (FIT ) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali; 2014. [cited 16 June 2021]. Available from: http://corehta.info/ViewCover.aspx?id=206